Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
21.10
-0.84 (-3.83%)
At close: Jul 24, 2026, 4:00 PM EDT
21.10
0.00 (0.00%)
After-hours: Jul 24, 2026, 4:00 PM EDT
Seaport Therapeutics Employees
Seaport Therapeutics had 58 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
58
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,502,828
Market Cap
1.13B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 58 | 0 | - |
| Dec 31, 2025 | 58 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 678 |
| MannKind | 592 |
| Ardelyx | 489 |
| Wave Life Sciences | 317 |
| Alpha Tau Medical | 121 |
| Inhibrx Biosciences | 110 |
| ORIC Pharmaceuticals | 104 |
SPTX News
- 9 days ago - Seaport Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 10 days ago - Seaport Therapeutics participates in a conference call with JPMorgan - TheFly
- 17 days ago - Seaport Therapeutics initiated with a Peer Perform at Wolfe Research - TheFly
- 6 weeks ago - Seaport Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers - Business Wire
- 6 weeks ago - Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year - TheFly
- 6 weeks ago - Seaport Therapeutics sees cash runway into 2029 - TheFly
- 6 weeks ago - Seaport announces data from MAD part of Phase 1 trial of GlyphAgo - TheFly